id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-P-6100-0034,FDA,FDA-2019-P-6100,Response Letter from CBER to American Association of Tissue Banks,Other,Letter(s),2020-06-09T04:00:00Z,2020,6,2020-06-09T04:00:00Z,,2020-06-09T16:19:01Z,,0,0,09000064846dbb88
FDA-2019-P-6100-0033,FDA,FDA-2019-P-6100,Letter from American Association of Tissue Banks to CBER,Other,Letter(s),2020-06-09T04:00:00Z,2020,6,2020-06-09T04:00:00Z,,2020-06-09T16:17:21Z,,0,0,09000064846dbb87
FDA-2019-P-6100-0031,FDA,FDA-2019-P-6100,Interim Response Letter from FDA CBER to American Association of Tissue Banks (AATB),Other,Letter(s),2020-05-06T04:00:00Z,2020,5,2020-05-06T04:00:00Z,,2020-05-06T16:09:26Z,,0,0,0900006484568fde